1 高玉珠,李爱阳,王晓宇,等.北京市密云区产后妇女避孕知识知晓情况及相关影响因素分析.中国计划生育学杂志,2017,25:524-527.
2 杨玉培,刘玉玲,郭沛沛,等.344例女性产后1年内意外妊娠人工流产调查.实用医学杂志,2016,32:659-661.
3 吴尚纯,楚光华.产后避孕的国内外指南.中国计划生育和妇产科,2012,4:11-15.
4 World Health Organization (WHO),Report of a WHO Technical Consultation on Birth Spacing.Geneva:WHO.Press,2005:1-48.
5 Mahande MJ.Effect of interpregnancy interval on adverse pregnancy outcomes in northern Tanzania :a registry-based retrospective cohort study.BMC pregnancy childbirth,2016,16:140.
6 Sridhar A.Optimizing maternal and neonatal outcomes with postpartum contraception:impact on breastfeeding and birth spacing.Matern Health Neonatol Perinatol,2017,3:1.
7 陈利琼,雪琼,华妹,等.剖宫产子宫切口疤痕妊娠16例临床分析.中国妇幼保健,2010,25:3561-3562.
8 WHO.Programming health strategy.to accelerate progress towards the attainment of international development goals and targets.Geneva:WHO,2014.
9 吕丽华,张亦心,田慧艳,等.高危人工流产调查分析及对策.中国妇幼保健,2013,28:2267-2268.
10 林明英,许林芬,付丽冬.某院人工流产2601例主要特征与避孕指导效果评价.海峡预防医学杂志,2017,23:106-107.
11 陈蔚琳,吕昌帅,刘欣燕.产后避孕认识的误区及对策.中国计划生育和妇产科,2019,11:15-17.
12 女性避孕方法临床应用的中国专家共识.中华妇产科杂志,2018,53:433-447.
13 Fabic MS,Choi Y.Assessing the quality of data regarding use of the lactational amenorrhea method.Stud Fam Plann,2013,44:205-221.
14 Curtis KM,Tepper NK,Jatlaoui TC,et al.U.S.Medical Eligibility Criteria for Contraceptive Use,2016.MMWR Recomm Rep,2016,65:1-103.
15 Committee opinion No.670:immediate postpartum long-acting reversible Contraception.Obstet Gynecol,2016,128:e32-37.
16 Department of Reproductive Health,World Health Organization.Medical eligibility criteria for contraceptive use.5th ed,WHO Press,Geneva,Switzerland,2015.
17 Berry-Bibee EN,Tepper NK,Jatlaoui TC,et al.The safety of intrauterine devices in breastfeeding women:a systematic review.
Contraception,2016,94:725-738.
18 Bahamondes L,Brache V,Meirik O,et al.A 3-year multicentre randomized controlled trial of etonogestrel-and Levonorgestrel-releasing contraceptive implants,with non-randomized matched copper-intrauterine device controls.Hum Reprod,2015,30:2517-2538.
19 Aoun J,Dines VA,Stovall DW,et al.Effects of age,parity.and device type on complications and discontinuation of intrauterine devices.Obstet Gynecol,2014,123:585-592.
20 Royal College of Obstetricians and Gynaecologists (RCOG) with the British Society for Gynaecological Endoscopy (BSGE).Management of Endometrial Hyperplasia.Green-top Guideline No.67. RCOG/BSGE Joint Guideline.London,2016.
21 Dunson TR,苏慧.哺乳期妇女应用单纯孕激素口服避孕药的多中心临床试验.国外医学(计划生育分册),1993,12:224-225,213.
22 Akadri AA.Progestogen-only injectable contraceptive:Acceptor prevalence and client experience at Sagamu,Nigeria.Niger Postgrad Med J,2017,24:178-181.
23 中华医学会计划生育学分会.临床诊疗指南与技术操作规范计划生育学分册.2017修订版.北京:人民卫生出版社.2017:31-41.
24 Phillips SJ,Tepper NK,Kapp N,et al.Progestogen-only Contraceptive use among breastfeeding women:a systematic review.Contraception,2016,94:226-252.
25 Harrison-Woolrych M,Hill R.Unintended pregnancies with the etonogestrel implant (Implanon):a case series from postmarketing experience in Australia.Contraception,2005,71:306-308.
26 曹莹,冯丽华.口服避孕药的发展及应用.吉林医学,2010,31:536-538.
27 Sénat MV,Sentilhes L,Battut A,et al.Postpartum practice:guidelines for clinical practice from the French College of Gynaecologists and Obstetricians(CNGOF).Eur J Obstet Gynecol Reprod Biol,2016,202:1-8.
28 中华医学会妇产科学分会产科学组.孕前和孕期保健指南(2018).中华妇产科杂志,2018,53:7-13.
29 滕莉荣,邱琳,欧婕,等.产后避孕时机的把握.中国计划生育和妇产科,2019,11:7-10.
30 Hu X,Cheng L,Hua X,et al.Advanced provision of emergency contraception to postnatal women in China makes no difference in abortion rates:a randomized controlled trial.Contraception,2005,72:111-116.
